Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
| Revenue | $3.08B | $2.45B | $2.58B | $2.63B |
| Revenue growth | — | -20.5% | 5.5% | 1.8% |
| Operating income | $140M | -$14.5M | -$18.1M | $97.1M |
| Operating margin | 4.5% | -0.6% | -0.7% | 3.7% |
| Net income | -$300K | -$1.10B | -$362M | -$198M |
| Net margin | -0.0% | -45.0% | -14.0% | -7.5% |
| EPS (diluted) | $0.00 | -$4.58 | -$1.43 | -$0.70 |
| Fiscal year | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
| Operating cash flow | $346M | $397M | -$166M | $24.8M |
| Capital expenditures | $6.50M | $9.90M | $13.5M | $13.4M |
| Free cash flow | $340M | $387M | -$180M | $11.4M |
| Fiscal year | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
| Cash & equivalents | $251M | $277M | $213M | $342M |
| Total assets | — | $5.10B | $6.82B | $5.33B |
| Total liabilities | — | $6.13B | $7.08B | $6.38B |
| Long-term debt | — | $923M | $1.84B | $1.78B |
| Shareholders' equity | $786M | -$1.15B | -$265M | -$1.19B |
| Retained earnings | — | -$1.25B | -$3.53B | -$3.73B |
| Shares (wtd avg diluted) | 253M | 244M | 249M | 285M |
Every figure is extracted from Lionsgate Studios Corp.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.